The therapy for urogenital tuberculosis

Authors : Ekaterina KULCHAVENYA, Mete ÇEK

Pages : 377-382

Doi:10.5472/marumj.1368375

View : 10 | Download : 37

Publication Date : 2023-09-29

Article Type : Review Paper

Abstract :Tuberculosis insert ignore into journalissuearticles values(TB); is a communicable disease that is a major cause of ill health. Urogenital TB was a frequent urological disease in the pre-antibiotic era: about 20% of patients in urological hospitals had renal TB, mostly in the form of pyonephrosis. We composed a narrative review of the literature with keywords “urogenital tuberculosis’, “prostate tuberculosis” “kidney tuberculosis”, “treatment of tuberculosis”. Urogenital TB insert ignore into journalissuearticles values(UGTB); includes TB of the kidney and the urinary tract and male and female genital TB. Each clinical presentation requires tailored antibiotic therapy depending on stage and general management. Anti-TB therapy should be multicomponent, continuous, long-lasting and controlled with a follow-up for 2-3 years. Otherwise, the risks of development of drug-resistance and relapse increase. Index of suspicion on UGTB is generally low, causing a delay in diagnosis; consequently, complicated forms of UGTB respond poorly to anti-TB therapy, while timely diagnosed “minor” forms are curable medically without surgery. Even with timely diagnosed UGTB, non-optimal therapy may result in over-fibrosis, scarring and strictures of the urinary tract, making surgical repair inevitable. Nevertheless, we have a wide enough spectrum of anti-TB drugs to cure urogenital TB.
Keywords : Urogenital tuberculosis, Prostate tuberculosis, Kidney tuberculosis, Prostate tuberculosis, Treatment